Blue chips rose for a third straight session on Thursday, with gains led by the transportation, construction and industrial products & services sectors due to bargain hunting interest in data-centre linked counters. The FBM KLCI gained another 10.66 points to end at the day's high of 1,585.17, off an early low of 1,573.90, as gainers led losers 489 to 388 on a slightly higher turnover of 2.93bn shares worth RM2.11bn.
The local market may enter consolidation mode ahead of the weekend, with investors sidelined ahead of the release of key U.S. employment data tonight for clearer direction on the Federal Reserve's future interest rate policy. Immediate index resistance is maintained at 1,605, with next upside hurdles at 1,630, followed by 1648. Immediate support remains at 1,550, with stronger supports at the 6/8/24 low of 1,529 and 1,500 psychological level.
Duopharma have a good potential recovery upside to the 38.2%FR (RM1.28), while a confirmed breakout should target the 50%FR (RM1.34) and 61.8%FR (RM1.40) going forward, with downside cushioned by retracement support at the lower Bollinger band (RM1.19) and RM1.15. Pharmaniaga is breaking out from current consolidation, with near-term upside target at the 50%FR (36sen), followed by tougher hurdles at the 61.8%FR (40sen) and 76.4%FR (44sen) ahead, while key uptrend supports come from the 23.6%FR (28sen) and 25sen.
Source: TA Research - 7 Feb 2025
Chart | Stock Name | Last | Change | Volume |
---|
2025-02-07
BAT2025-02-07
BAT2025-02-07
BAT2025-02-07
BAT2025-02-07
BIMB2025-02-07
BIMB2025-02-07
BIMB2025-02-07
BIMB2025-02-07
BIMB2025-02-07
BPURI2025-02-07
BPURI2025-02-07
BPURI2025-02-07
BPURI2025-02-07
DPHARMA2025-02-07
DPHARMA2025-02-07
GAMUDA2025-02-07
GAMUDA2025-02-07
GAMUDA2025-02-07
GAMUDA2025-02-07
GAMUDA2025-02-07
IHH2025-02-07
IHH2025-02-07
IHH2025-02-07
IHH2025-02-07
IHH2025-02-07
IHH2025-02-07
IHH2025-02-07
IHH2025-02-07
IHH2025-02-07
INARI2025-02-07
INARI2025-02-07
LCTITAN2025-02-07
LCTITAN2025-02-07
LCTITAN2025-02-07
LCTITAN2025-02-07
LCTITAN2025-02-07
LCTITAN2025-02-07
LFG2025-02-07
MNHLDG2025-02-07
MNHLDG2025-02-07
MNHLDG2025-02-07
MNHLDG2025-02-07
NORTHERN2025-02-07
NORTHERN2025-02-07
NOTION2025-02-07
NOTION2025-02-07
NOTION2025-02-07
NOTION2025-02-07
NOTION2025-02-07
PHARMA2025-02-07
PHARMA2025-02-07
SCOMIES2025-02-07
SCOMIES2025-02-07
SCOMIES2025-02-07
SCOMIES2025-02-07
SCOMIES2025-02-07
SCOMIES2025-02-07
ZECON2025-02-07
ZECON2025-02-07
ZECON2025-02-06
BAT2025-02-06
BIMB2025-02-06
BIMB2025-02-06
BIMB2025-02-06
GAMUDA2025-02-06
GAMUDA2025-02-06
GAMUDA2025-02-06
GAMUDA2025-02-06
GAMUDA2025-02-06
GAMUDA2025-02-06
GAMUDA2025-02-06
GAMUDA2025-02-06
GAMUDA2025-02-06
IHH2025-02-06
IHH2025-02-06
IHH2025-02-06
INARI2025-02-06
MNHLDG2025-02-06
NORTHERN2025-02-06
NOTION2025-02-06
NOTION2025-02-06
ZECON2025-02-05
BIMB2025-02-05
BPURI2025-02-05
BPURI2025-02-05
GAMUDA2025-02-05
GAMUDA2025-02-05
GAMUDA2025-02-05
GAMUDA2025-02-05
GAMUDA2025-02-05
IHH2025-02-05
IHH2025-02-05
IHH2025-02-05
LFG2025-02-05
LFG2025-02-05
MNHLDG2025-02-04
BPURI2025-02-04
BPURI2025-02-04
GAMUDA2025-02-04
GAMUDA2025-02-04
GAMUDA2025-02-04
GAMUDA2025-02-04
GAMUDA2025-02-04
GAMUDA2025-02-04
IHH2025-02-04
IHH2025-02-04
LFG2025-02-04
LFG2025-02-03
BIMB2025-02-03
BIMB2025-02-03
BIMB2025-02-03
BIMB2025-02-03
BIMB2025-02-03
DPHARMA2025-02-03
GAMUDA2025-02-03
GAMUDA2025-02-03
GAMUDA2025-02-03
GAMUDA2025-02-03
GAMUDA2025-02-03
GAMUDA2025-02-03
GAMUDA2025-02-03
IHH2025-02-03
IHH2025-02-03
IHH2025-02-03
IHH2025-02-03
LFG2025-02-03
LFG2025-02-03
LFG2025-02-03
PHARMA2025-02-03
SCOMIES2025-02-03
SCOMIES2025-01-31
BIMB2025-01-31
GAMUDA2025-01-31
GAMUDA2025-01-31
GAMUDA2025-01-31
GAMUDA2025-01-31
GAMUDA2025-01-31
GAMUDA2025-01-31
GAMUDA2025-01-31
IHH2025-01-31
SCOMIES2025-01-31
SCOMIES2025-01-31
SCOMIES2025-01-31
SCOMIES2025-01-31
SCOMIES2025-01-31
SCOMIES2025-01-29
GAMUDA2025-01-28
BIMB2025-01-28
BPURI2025-01-28
BPURI2025-01-28
BPURI2025-01-28
GAMUDA2025-01-28
GAMUDA2025-01-28
IHH2025-01-28
IHH2025-01-28
LFG2025-01-28
LFG2025-01-28
LFG2025-01-28
LFGCreated by sectoranalyst | Feb 06, 2025